July 31, 2024 BHR Newsletter 1. Another US drugmaker on the verge of closure: Report Full story 2. 25-person obesity pill trial earns drugmaker $16.8B Full story 3. Could Amazon be headed for big healthcare losses? Full story 4. 1…
Life Sciences
July 24, 2024 BHR Newsletter 1. 'Best' weight loss drug remains elusive Full story 2. 10 top execs that have recently left Optum Full story 3. The state of drug shortages: ASHP Full story 4. 1 MD is 'democratizing expertise'…
July 17, 2024 BHR Newsletter 1. A rising market for 'faux-zempic' Full story 2. JD Vance's healthcare record: What hospital leaders should know Full story 3. Cancer drug shortage: 8 updates Full story 4. Streamline your clinical trial workflow and…
July 10, 2024 BHR Newsletter 1. Eli Lilly plans for $3.2B purchase Full story 2. Insurers brought in $50B through 'questionable' Medicare Advantage coding: WSJ Full story 3. Ozempic vs. Mounjaro: Which fared better in 1st large study Full story…
July 3, 2024 BHR Newsletter 1. Biden, Sanders to Ozempic maker: 'Stop ripping off' Americans Full story 2. Chevron ruling may hinder drug development, experts say Full story 3. FTC probes Teva over drug patents Full story 4. Health systems…
Advertisement
June 26, 2024 BHR Newsletter 1. J&J acquires immune disease biologics company for $850M Full story 2. Teva launches first generic GLP-1 Full story 3. Eli Lilly hits phony drugmakers with 6 more lawsuits Full story 4. Added ASC-covered procedures…
June 12, 2024 BHR Newsletter 1. Sanders calls vote to subpoena Novo Nordisk president Full story 2. Proposed legislation hopes to remove healthcare 'corporate greed': 7 things to know Full story 3. FDA panel votes in favor of Alzheimer's drug…
June 5, 2024 BHR Newsletter 1. Novartis sues Maryland over law prohibiting restrictions on 340B drugs Full story 2. Fortune 500's top 25 healthcare companies Full story 3. Sagent recalls 2 lots of cancer drug Full story 4. It's time…
May 29, 2024 BHR Newsletter 1. J&J to buy skin drug for $1.25B Full story 2. 12 health systems moving to Epic Full story 3. Pfizer recalls 5 drug lots for potential packaging error Full story 4. 4 systems' nurse…
May 22, 2024 BHR Newsletter 1. AstraZeneca to pay $107.5M for cancer drug patent infringement Full story 2. 10 highest-paid healthcare CEOs Full story 3. FDA approves 2 Eylea biosimilars Full story 4. 600+ infusion centers are increasing volumes with…